News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dilaforette is Granted SEK 2.8M for Development of Sevuparin for the Treatment of Severe Malaria



11/2/2012 2:31:59 PM

STOCKHOLM – November 2, 2012. Dilaforette announces today that it has been granted SEK 2.85m from the Swedish Governmental Agency for Innovation Systems, Vinnova, for the development of sevuparin, a new potential treatment for severe malaria.

Read at PharmaLive


comments powered by Disqus
 
 
Malaria

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES